Harvard Business Review

OCTOBER 21, 2013

I found myself reflecting on this recently while speaking with two business leaders in one of the world’s great pharmaceutical companies. Over the course of our conversation, the executives and I arrived at the hot topic of authenticity. Strength in Diverse, Collaborative Teams. It’s a tough challenge.

Drucker 8

Drucker Diversity Pharmaceuticals Uncertainty 8

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

NOVEMBER 8, 2017

But replicating the facility- and labor-intensive American model — which is more costly than that of any other nation yet produces subpar results — will set these emerging economies on the same course of endless cost escalation that has plagued the United States. Over the same period, pharmaceutical exports have doubled.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Strategy Driven

MARCH 18, 2011

They cannot chart a future course based on a wide-eyed search for external growth: “There’s an attractive, adjacent market. Moreover, fixed assets are more difficult to leverage across diverse businesses than capabilities, and they tend to expire, become obsolete, or give way to related services. Let’s go after it.”

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

MARCH 2, 2012

They are remarkably open to talented people from diverse backgrounds, and are highly skilled at giving future leaders the knowledge and experience they need to lead successfully in the global economy. companies actively promote executive officers with diverse geographic and cultural backgrounds.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

JANUARY 31, 2013

The megatrend in demand, of course, is the shift to developing economies. On the innovation front, the opportunities are more diverse, but equally powerful. Pharmaceutical companies are mastering bio-engineering techniques that will help develop personalized medicines. Innovations Are Changing The Way We Design Products.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

JUNE 20, 2017

Prasad, CEO of Dr. Reddy’s, a 33-year-old global pharmaceutical company headquartered in India that produces affordable generic medication. Over the course of several months, the Dr. Reddy’s team worked with IDEO to learn about the needs of everyone, from shop floor workers to scientists, external partners, and investors.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

DECEMBER 5, 2016

It serves vastly diverse populations: toddlers and caregivers, new immigrants, lifelong learners, famous novelists, and scholars. How to provide hyper-local services tailored to the diverse needs of its patrons while also upholding a consistent and high standard of service? Of course, more usage is good news.

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

AUGUST 23, 2018

percentage points and course reductions fell by 15.3 Employers are also able to expose a more diverse population to potential careers in their industries. Arrests in the 18 months following participation in the program decreased by 35% for violent crimes and by 57% for property crimes, relative to the control group. percentage points.

Short-term 8

Short-term Participative Long-term Career 8

Harvard Business Review

MAY 10, 2018

” Another executive walking the tightrope of managing her underrepresented identity, Mara (SVP, Pharmaceuticals), told us, “I was black, they were white…I was female, they were all male…There was nothing that was an obvious similarity between us. Not edgy but not without edge; soft but not too soft.”

Execution 11

Execution Strategy Self-aware Career 11

Cooperperson

OCTOBER 21, 2019

By the grace of God and connecting with generous people, Ellen got to the chairman of Merck Sharp & Dohme, one of the largest pharmaceutical companies in the world. He’s brought together a diverse group of people – a few are famous, most are not – who’ve faced a myriad of challenges and prevailed.

Chief Operating Officer 12

Chief Operating Officer Open-book Books Entrepreneur 12

Strategy Driven

JANUARY 24, 2011

’) Of course, time has marched on since the book was written, and plenty of other well-known companies have dropped the execution ball in the meantime (BP in the most spectacular fashion). It is these bridges that differentiate the companies that are consistently able to get things done from those that aren’t. (I

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

NOVEMBER 28, 2017

Of course, markets are imperfect. How many consumers understand the nature of pharmaceutical research, how market prices affect oil companies, how credit card providers operate, or what investment banks actually do? In the sample of firms we used, KLD scores were positively correlated with firms’ incomes.

Company 8

Company Short-term Long-term Price 8

Harvard Business Review

MARCH 8, 2011

Lafley became the CEO of Procter & Gamble, he saw that the company's current expansion strategy, which had put it in markets as diverse as pharmaceuticals and snack foods, would continue to erode value. It is your legacy you're looking for; a generic or tradition-bound view of success won't suffice. But the rewards are profound.

Merchandising 14

Merchandising Budgeting Pharmaceuticals CEO 14

Harvard Business Review

JUNE 24, 2015

Managers and other business leaders face a dilemma: with increasingly diverse environments to manage and rising stakes to get it right, how do they identify the most effective approach to business strategy and marshal the right thinking and behaviors to conceive and execute it, supported by the appropriate frameworks and tools? Add to Cart.

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

APRIL 8, 2011

Yeah, we hold up half the sky," recently quipped a female senior manager for a multinational pharmaceutical company, "but there are 5,000 years of history dragging us back.". Of course, I miss the chance to be with my daughter, but working mothers have to focus more on work," she says stoically.

Flextime 11

Flextime Career Competitive Advantage Pharmaceuticals 11